Klingman & Associates, LLC Q4 2022 Filing

Filed February 3, 2023

Portfolio Value

$1.1T

Holdings

203

Report Date

Q4 2022

Filing Type

13F-HR

All Holdings (203 positions)

#StockSharesValue% PortfolioType
201
XEMDXWESTERN ASSET EMERGING MKTS
13,581$123.7M0.01%
202
NKTREURNEKTAR THERAPEUTICS
35,063$79.2M0.01%
203
DRIOEURDARIOHEALTH CORP
17,850$76.4M0.01%
PreviousPage 3 of 3